Am J Perinatol 2010; 27(8): 603-610
DOI: 10.1055/s-0030-1249362
© Thieme Medical Publishers

Asymmetric Large-for-Gestational-Age Infants of Type 1 Diabetic Women: Morbidity and Abdominal Growth

Sureka Bollepalli1 , Lawrence M. Dolan1 , Menachem Miodovnik2 , Maisa Feghali2 , Jane C. Khoury3
  • 1Division of Endocrinology, Cincinnati Children's Hospital Medical Center and University of Cincinnati School of Medicine, Cincinnati, Ohio
  • 2Department of Obstetrics and Gynecology, Professor of Obstetrics and Gynecology, Georgetown University, Washington Hospital Center, Washington, DC
  • 3Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center and University of Cincinnati School of Medicine, Cincinnati, Ohio
Further Information

Publication History

Publication Date:
11 March 2010 (online)

ABSTRACT

We sought to examine neonatal morbidity in four groups of offspring (asymmetric large for gestational age [LGA], symmetric LGA, asymmetric non-LGA, symmetric non-LGA) exposed in utero to maternal type 1 diabetes, and the association between rate of fetal abdominal circumference growth and asymmetric LGA. We performed a secondary analysis of 302 singleton pregnancies. Neonatal morbidity (respiratory distress syndrome, polycythemia, hypoglycemia, hyperbilirubinemia, acidosis, and composite morbidity [any of the five]) was assessed. Serial ultrasound examinations after 20 weeks' gestation were available for 35 fetuses. Logistic regression and general linear mixed modeling were used for analysis. Asymmetric LGA infants had 3.5-, 2.2-, and 3.2-fold greater odds of hypoglycemia, hyperbilirubinemia, and composite morbidity, respectively, compared with symmetric non-LGA infants. The rate of growth of the abdominal circumference in asymmetric LGA infants (1.11 cm/wk) was greater than for both the symmetric LGA infants (0.87 cm/wk, p = 0.09) and the symmetric non-LGA infants (0.87 cm/wk, p = 0.03). Asymmetric LGA infants are at higher risk for morbidity than symmetric LGA and non-LGA infants. Intrauterine growth rate of the abdominal circumference may potentially be used as a marker to identify the asymmetric LGA and thereby aid in the identification of newborns at greatest risk for perinatal complications.

REFERENCES

  • 1 Evers I M, de Valk H W, Visser G H. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands.  BMJ. 2004;  328 915
  • 2 Taylor R, Lee C, Kyne-Grzebalski D, Marshall S M, Davison J M. Clinical outcomes of pregnancy in women with type 1 diabetes(1).  Obstet Gynecol. 2002;  99 537-541
  • 3 Mondestin M A, Ananth C V, Smulian J C, Vintzileos A M. Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy.  Am J Obstet Gynecol. 2002;  187 922-926
  • 4 Siddiqui F, James D. Fetal monitoring in type 1 diabetic pregnancies.  Early Hum Dev. 2003;  72 1-13
  • 5 Ballard J L, Rosenn B, Khoury J C, Miodovnik M. Diabetic fetal macrosomia: significance of disproportionate growth.  J Pediatr. 1993;  122 115-119
  • 6 Jährig D, Jährig K, Stiete S, Beyersdorff E, Poser H, Hopp H. Neonatal jaundice in infants of diabetic mothers.  Acta Paediatr Scand Suppl. 1989;  360 101-107
  • 7 Dupak J DL. Ultrasound surveillance in pregnancy complicated by diabetes.  Diabetes Spectrum. 2007;  20 89-93
  • 8 Landon M B. Prenatal diagnosis of macrosomia in pregnancy complicated by diabetes mellitus.  J Matern Fetal Med. 2000;  9 52-54
  • 9 Bernstein I M, Catalano P M. Influence of fetal fat on the ultrasound estimation of fetal weight in diabetic mothers.  Obstet Gynecol. 1992;  79 561-563
  • 10 Greco P, Vimercati A, Scioscia M, Rossi A C, Giorgino F, Selvaggi L. Timing of fetal growth acceleration in women with insulin-dependent diabetes.  Fetal Diagn Ther. 2003;  18 437-441
  • 11 Siddiqi T A, Miodovnik M, Mimouni F, Clark E A, Khoury J C, Tsang R C. Biphasic intrauterine growth in insulin-dependent diabetic pregnancies.  J Am Coll Nutr. 1989;  8 225-234
  • 12 Kaplan L A, Cline D, Gartside P, Burstein S, Sperling M, Stein E A. Hemoglobin A1 in hemolysates from healthy and insulin-dependent diabetic children, as determined with a temperature-controlled minicolumn assay.  Clin Chem. 1982;  28 13-18
  • 13 Campbell S, Newman G B. Growth of the fetal biparietal diameter during normal pregnancy.  J Obstet Gynaecol Br Commonw. 1971;  78 513-519
  • 14 Deter R L, Harrist R B, Hadlock F P, Carpenter R J. The use of ultrasound in the assessment of normal fetal growth: a review.  J Clin Ultrasound. 1981;  9 481-493
  • 15 Hadlock F P, Harrist R B, Sharman R S, Deter R L, Park S K. Estimation of fetal weight with the use of head, body, and femur measurements—a prospective study.  Am J Obstet Gynecol. 1985;  151 333-337
  • 16 Campbell S, Wilkin D. Ultrasonic measurement of fetal abdomen circumference in the estimation of fetal weight.  Br J Obstet Gynaecol. 1975;  82 689-697
  • 17 Shepard M J, Richards V A, Berkowitz R L, Warsof S L, Hobbins J C. An evaluation of two equations for predicting fetal weight by ultrasound.  Am J Obstet Gynecol. 1982;  142 47-54
  • 18 Djelmis J, Buković D, Pfeifer D, Ivanisević M. Ponderal index and disproportionate fetal growth in IDDM pregnancies.  Coll Antropol. 1998;  22 491-495
  • 19 Akcakus M, Koklu E, Kurtoglu S, Kula M, Koklu S S. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.  Am J Perinatol. 2006;  23 473-480
  • 20 Pedersen J. Weight and length at birth of infants of diabetic mothers.  Acta Endocrinol (Copenh). 1954;  16 330-342
  • 21 Schaefer-Graf U M, Kjos S L, Bühling K J et al.. Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes.  Diabet Med. 2003;  20 349-354
  • 22 Susa J B, Gruppuso P A, Widness J A et al.. Chronic hyperinsulinemia in the fetal rhesus monkey: effects of physiologic hyperinsulinemia on fetal substrates, hormones, and hepatic enzymes.  Am J Obstet Gynecol. 1984;  150 415-420
  • 23 Vela-Huerta M M, San Vicente-Santoscoy E U, Guizar-Mendoza J M, Amador-Licona N, Aldana-Valenzuela C, Hernnández J. Leptin, insulin, and glucose serum levels in large-for-gestational-age infants of diabetic and non-diabetic mothers.  J Pediatr Endocrinol Metab. 2008;  21 17-22
  • 24 Hay Jr W W. Recent observations on the regulation of fetal metabolism by glucose.  J Physiol. 2006;  572(Pt 1) 17-24
  • 25 Catalano P M, Thomas A, Huston-Presley L, Amini S B. Increased fetal adiposity: a very sensitive marker of abnormal in utero development.  Am J Obstet Gynecol. 2003;  189 1698-1704
  • 26 Chiesa C, Osborn J F, Haass C et al.. Ghrelin, leptin, IGF-1, IGFBP-3, and insulin concentrations at birth: is there a relationship with fetal growth and neonatal anthropometry?.  Clin Chem. 2008;  54 550-558
  • 27 Koklu E, Kurtoglu S, Akcakus M, Yikilmaz A, Gunes T. Serum insulin-like growth factor-I (IGF-I) IGF binding protein-3 (IGFBP-3) and leptin levels are related to abdominal aortic intima-media thickness in macrosomic newborns.  Growth Horm IGF Res. 2007;  17 26-32
  • 28 Lepercq J, Lahlou N, Timsit J, Girard J, Mouzon S H. Macrosomia revisited: ponderal index and leptin delineate subtypes of fetal overgrowth.  Am J Obstet Gynecol. 1999;  181 621-625
  • 29 Susa J B, Widness J A, Hintz R, Liu F, Sehgal P, Schwartz R. Somatomedins and insulin in diabetic pregnancies: effects on fetal macrosomia in the human and rhesus monkey.  J Clin Endocrinol Metab. 1984;  58 1099-1105
  • 30 Raychaudhuri K, Maresh M J. Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes.  Obstet Gynecol. 2000;  95 190-194
  • 31 Ashworth M A, Leach F N, Milner R D. Development of insulin secretion in the human fetus.  Arch Dis Child. 1973;  48 151-152
  • 32 Buchanan T A, Kjos S L, Montoro M N et al.. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes.  Diabetes Care. 1994;  17 275-283
  • 33 Buchanan T A, Kjos S L, Schafer U et al.. Utility of fetal measurements in the management of gestational diabetes mellitus.  Diabetes Care. 1998;  21(Suppl 2) B99-B106
  • 34 Kjos S L, Schaefer-Graf U, Sardesi S et al.. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia.  Diabetes Care. 2001;  24 1904-1910
  • 35 Lande B, Andersen L F, Henriksen T et al.. Relations between high ponderal index at birth, feeding practices and body mass index in infancy.  Eur J Clin Nutr. 2005;  59 1241-1249
  • 36 Pietiläinen K H, Kaprio J, Räsänen M, Winter T, Rissanen A, Rose R J. Tracking of body size from birth to late adolescence: contributions of birth length, birth weight, duration of gestation, parents' body size, and twinship.  Am J Epidemiol. 2001;  154 21-29

Sureka BollepalliM.D. 

Division of Endocrinology, Clinical Fellow, Cincinnati Children's Hospital Medical Center and University of Cincinnati School of Medicine

MLC 7012, 3333 Burnet Avenue, Cincinnati, OH 45208

Email: surekabollepalli@yahoo.com

    >